ZOOMMED INC. Inactive Instrument
ZoomMed Inc. Share Price Other OTC
Equities
Advanced Medical Equipment & Technology
| Sales 2022 | 11.15T 8.18T 7L | Sales 2023 | 13.01T 9.54T 8L | Capitalization | 20.34L 14.91L 12Cr |
|---|---|---|---|---|---|
| Net income 2022 | -10L -7L -6.12Cr | Net income 2023 | - 0 0 | EV / Sales 2022 | 168 x |
| Net cash position 2022 | 2L 1L 98.28L | Net Debt 2023 | 4L 3L 2.4Cr | EV / Sales 2023 | 186 x |
| P/E ratio 2022 |
-1.66
x | P/E ratio 2023 |
11.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.02% |
More Fundamentals
* Assessed data
More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Yves Marmet
CEO | Chief Executive Officer | - | 01/05/01 |
| Director of Finance/CFO | - | 01/05/01 | |
Sébastie Ouellet
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Robert Powell
BRD | Director/Board Member | - | 01/05/01 |
André Marmet
PRN | Corporate Officer/Principal | - | 01/05/01 |
| Director of Finance/CFO | - | 01/05/01 |
ZoomMed Inc. is a Canada-based company, which builds and operates ZoomMedâs Communication Network, a clinical interoperable information exchange network between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers.
Calendar
27/09/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.49% | 2.82TCr | |
| +25.35% | 832.85Cr | |
| +33.25% | 439.32Cr | |
| -35.85% | 243Cr | |
| -9.44% | 160.35Cr | |
| -13.39% | 149.66Cr | |
| -32.84% | 114.66Cr | |
| +7.80% | 96Cr | |
| -37.56% | 87Cr |
